Cardio-Oncology: Far Beyond Doxorubicin and the Tip of the Iceberg!
Cardio-oncology is a new field of work and research on the adverse cardiovascular effects of cancer treatment, comorbidities and clinical conditions in cancer patients, and cardiovascular tumors. It has a wide spectrum ranging from arterial hypertension, arrhythmias, coronary and thromboembolic diseases to ventricular dysfunction, among others. In this special issue of ABC Heart Failure, we will focus on myocardial lesions, and consequently cardiomyopathies, ventricular dysfunction and heart failure (HF).
The Department of HF of the Brazilian Society of Cardiology has embraced Cardio-oncology since its beginning, by opening space for scientific discussion in its events and thematic area for abstract submissions, and now by offering this special issue addressing the main manifestations of endomyocardial/pericardial diseases and HF in cancer patients.
[…]
Comments are moderated by the editorial team before publication. Discussions should be evidence-based and use scientific language. Conflicts of interest should be declared.